Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07336420 · ClinicalTrials.gov registry record · Phase 4
Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment
A Phase 4 study, sponsored by Theranica.
- Completed
- Registry status
- Phase 4
- Development phase
- 466
- Enrollment target
NCT07336420 is a Phase 4 study that has completed, run by Theranica. The registered enrollment target is 466 participants.
The verdict
NCT07336420, a Phase 4 study, has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 466 participants
- Enrollment target
Study Summary
Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a primary focus on whether they need rescue medications following REN treatment. Findings from this study may help guide clinical decision-making as veterans and providers craft treatment plans that include non-pharmacologic options.
Interventions
- DEVICE Nerivio REN device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 466 participants |
| Start Date | 2026-01-09 |
| Est. Completion | 2026-01-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07336420
The ClinicalTrials.gov registry entry for NCT07336420 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 466 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranica, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nerivio REN device is the first listed.
NCT07336420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07336420 about?
NCT07336420 is a clinical study titled "Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment". Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a p...
What is the current status of trial NCT07336420?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 466 participants. The study started on 2026-01-09. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT07336420?
The interventions under investigation include: Nerivio REN device (DEVICE).
Who is sponsoring clinical trial NCT07336420?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.